Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-035143
Filing Date
2025-03-07
Accepted
2025-03-07 07:30:25
Documents
78
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K alvr-20241231.htm   iXBRL 10-K 3756303
2 EX-19.1 alvr-ex19_1.htm EX-19.1 148427
3 EX-23.1 alvr-ex23_1.htm EX-23.1 2848
4 EX-31.1 alvr-ex31_1.htm EX-31.1 18076
5 EX-32.1 alvr-ex32_1.htm EX-32.1 10838
  Complete submission text file 0000950170-25-035143.txt   11844075

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT alvr-20241231.xsd EX-101.SCH 1573744
81 EXTRACTED XBRL INSTANCE DOCUMENT alvr-20241231_htm.xml XML 1630863
Mailing Address 1100 WINTER STREET WALTHAM MA 02451
Business Address 1100 WINTER STREET WALTHAM MA 02451 (617) 433-2605
Allovir, Inc. (Filer) CIK: 0001754068 (see all company filings)

EIN.: 831971007 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39409 | Film No.: 25717573
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)